AS
Ascletis Pharma Inc.
ASCLF · OTC
$1.20 +0.00% (+$0.00)
1M -15.38%
Market Cap ¥7.72B
P/E Ratio -
Div. Yield -
ROE 17.44%
Piotroski F-Score Weak
1/9Valuation
25 /100
Expensive P/S 3,907.34x
P/B 3.99x
P/E N/A
Growth
0 /100
Declining Rev. growth 66.82%
Book val. growth 8.66%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 842.70%
Net margin 17,745.60%
Op. margin 23,854.00%
Quality
0 /100
Poor ROIC 24.25%
ROE 17.44%
ROA 16.96%
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 15.05x
Int. coverage -2,949.78x
Stability
13 /100
Unstable Beta 0.39x
Rev. volatility 77.39%
EPS volatility 93.54%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ASCLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jinzi J. Wu
Employees
202
Headquarters
Hangzhou
Nadcházející události
30 BŘE
Earnings
Upcoming earnings report